No Evidence That G6PD Deficiency Affects the Efficacy or Safety of Daunorubicin in Acute Lymphoblastic Leukemia Induction Therapy

BACKGROUND/OBJECTIVES: Anthracyclines are used in induction therapy of pediatric acute lymphoblastic leukemia (ALL) and are known to generate oxidative stress; whether this translates into enhanced anti-leukemic activity or hemolytic effects in patients with glucose-6-phosphate dehydrogenase (G6PD)...

詳細記述

保存先:
書誌詳細
出版年:Pediatr Blood Cancer
主要な著者: Robinson, Katherine M., Yang, Wenjian, Karol, Seth E., Kornegay, Nancy, Jay, Dennis, Cheng, Cheng, Choi, John K., Campana, Dario, Pui, Ching-Hon, Wood, Brent, Borowitz, Michael J., Gastier-Foster, Julie, Larsen, Eric C., Winick, Naomi, Carroll, William L., Loh, Mignon L., Raetz, Elizabeth A., Hunger, Stephen P., Devidas, Meenakshi, Mardis, Elaine R., Fulton, Robert S., Relling, Mary V., Jeha, Sima
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6518412/
https://ncbi.nlm.nih.gov/pubmed/30848065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.27681
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料